Hyperkalemia

• FDA approval · 2015-04-26
  FDA Approved: KIONEX — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approves a supplemental application for KIONEX (sodium polystyrene sulfonate) submitted by ANI Pharmaceuticals, Inc.

• FDA approval · 2014-11-28
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (SUNRISE PHARMACEUTICAL, INC.)

  FDA approved Sunrise Pharmaceutical, Inc.'s original application for sodium polystyrene sulfonate, a resin used to treat hyperkalemia.

• FDA approval · 2014-03-19
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (PuraCap Laboratories, LLC)

  FDA approved the original ANDA for Sodium polystyrene sulfonate from PuraCap Laboratories, LLC, providing a generic option for treating hype…

• FDA approval · 2012-09-25
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (CMP Pharma, Inc.)

  The FDA approved a supplemental application for CMP Pharma's sodium polystyrene sulfonate.

• FDA approval · 2011-11-08
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (KVK-Tech, Inc.)

  The FDA approved a supplemental application for sodium polystyrene sulfonate by KVK-Tech, Inc. (ANDA 040905), marking an approved change rel…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2011-06-24
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (CMP Pharma, Inc.)

  FDA approved a supplemental application for CMP Pharma's sodium polystyrene sulfonate under an ANDA, signaling an updated or expanded approv…

• FDA approval · 2011-03-03
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Supplemental Application (CMP Pharma, Inc.)

  FDA approves CMP Pharma, Inc.'s supplemental application for Sodium Polystyrene Sulfonate under ANDA087859.

• FDA approval · 2009-03-30
  FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (KVK-Tech, Inc.)

  FDA approved the original application for sodium polystyrene sulfonate from KVK-Tech, Inc., enabling a generic product for treating hyperkal…

• FDA approval · 2007-09-17
  FDA Approved: KIONEX — Original Application (ANI Pharmaceuticals, Inc.)

  The FDA approved ANI Pharmaceuticals' original application for KIONEX (sodium polystyrene sulfonate) to treat hyperkalemia.